Pancreatic Cancer Research

ResearcherJiangsu Province HospitalActive in the last 2 years

Peng Shen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5689-1098; OpenAlex author ID A5082972798. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2018: 1 paper · 2019: 2 papers · 2020: 3 papers · 2021: 4 papers · 2022: 3 papers · 2023: none · 2024: none · 2025: 2 papers

Papers 15

  1. Correction: YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT… Co-author DOI 10.1038/s41416-025-03061-x↗
  2. Editorial Expression of Concern to: The YY1/miR-548t-5p/CXCL11 signaling axis regulates cell proliferation and metastasis in human pancreatic cancer. Co-author DOI 10.1038/s41419-025-07740-8↗
  3. CircSTX6 promotes pancreatic ductal adenocarcinoma progression by sponging miR-449b-5p and interacting with CUL2. Co-author DOI 10.1186/s12943-022-01599-5↗
  4. Correction: CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-IRNA-editing. Co-author DOI 10.1186/s12943-022-01636-3↗
  5. Biological functions, mechanisms, and clinical significance of circular RNA in pancreatic cancer: a promising rising star. Co-author DOI 10.1186/s13578-022-00833-3↗
  6. Roundabout homolog 1 inhibits proliferation via the YY1-ROBO1-CCNA2-CDK2 axis in human pancreatic cancer. First author DOI 10.1038/s41388-021-01741-5↗
  7. CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing. Co-author DOI 10.1186/s12943-021-01333-7↗
  8. FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma. First author DOI 10.1186/s13046-021-02063-w↗
  9. Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fimmu.2021.800268↗
  10. Long noncoding RNA SOX2OT promotes the proliferation of pancreatic cancer by binding to FUS. Co-author DOI 10.1002/ijc.32827↗
  11. Linc01232 promotes the metastasis of pancreatic cancer by suppressing the ubiquitin-mediated degradation of HNRNPA2B1 and activating the A-Raf-induced MAPK/ERK… Co-author DOI 10.1016/j.canlet.2020.08.001↗
  12. The YY1/miR-548t-5p/CXCL11 signaling axis regulates cell proliferation and metastasis in human pancreatic cancer. Co-author DOI 10.1038/s41419-020-2475-3↗
  13. YY1 inhibits the migration and invasion of pancreatic ductal adenocarcinoma by downregulating the FER/STAT3/MMP2 signaling pathway. Co-author DOI 10.1016/j.canlet.2019.07.019↗
  14. YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT pathways. Co-author DOI 10.1038/s41416-019-0604-5↗
  15. CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s40659-017-0149-0↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qun Chen · 13 shared papers, 2019–2025 · strength 1.70
  2. Kuirong Jiang · 12 shared papers, 2019–2025 · strength 1.62
  3. Lingdong Meng · 12 shared papers, 2019–2025 · strength 1.57
  4. Wanli Ge · 11 shared papers, 2019–2025 · strength 1.45
  5. Xumin Huang · 11 shared papers, 2019–2025 · strength 1.43
  6. Hao Yuan · 11 shared papers, 2019–2025 · strength 1.37
  7. Yi Miao · 9 shared papers, 2019–2022 · strength 0.97
  8. Taoyue Yang · 7 shared papers, 2021–2022 · strength 0.87
  9. Yi Miao · 4 shared papers, 2022–2025 · strength 0.73
  10. Guodong Shi · 5 shared papers, 2020–2025 · strength 0.67
  11. Lei Chen · 4 shared papers, 2019–2025 · strength 0.52
  12. Zipeng Lu · 4 shared papers, 2021–2022 · strength 0.49
  13. Pengfei Wu · 4 shared papers, 2020–2022 · strength 0.46
  14. Jingjing Zhang · 4 shared papers, 2019–2021 · strength 0.42
  15. Pengfei Wu · 3 shared papers, 2021–2022 · strength 0.39
  16. Baobao Cai · 2 shared papers, 2021–2022 · strength 0.25
  17. Min Tu · 2 shared papers, 2020–2022 · strength 0.23
  18. Shouji Cao · 2 shared papers, 2020–2021 · strength 0.22
  19. Kuirong Jiang · 2 shared papers, 2020 · strength 0.20
  20. Qun Chen · 1 shared paper, 2021 · strength 0.12
  21. Yi Cai · 1 shared paper, 2018 · strength 0.12
  22. Dong Zhang · 1 shared paper, 2018 · strength 0.12
  23. Chuang Yang · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.